Proteomic analysis of wild type and arsenite-resistant Leishmania donovani

Experimental Parasitology

Volumn 123, Issue 4, 2009, Pages 369-376

  Sharma, Shruti ^a,b   Singh, Gaganmeet ^a,c   Chavan, Hemantkumar D ^a,d   Dey, Chinmoy S ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenite resistance; Leishmania donovani; Mass spectrometry; Post translational modifications; Proteomics; Two dimensional gel electrophoresis

Indexed keywords

AMINOMETHYLTRANSFERASE; ARSENIC TRIOXIDE; CENTRIN; CENTROMERE PROTEIN B; DEAD BOX PROTEIN; DYNEIN ADENOSINE TRIPHOSPHATASE; HISTONE H1; POLYADENYLIC ACID BINDING PROTEIN; PROTEIN TYROSINE PHOSPHATASE; UBIQUITIN PROTEIN LIGASE; URIDINE KINASE;

ARTICLE; CONTROLLED STUDY; GENETIC RESISTANCE; ISOELECTRIC POINT; LEISHMANIA DONOVANI; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN PROCESSING; PROTEOMICS; STRAIN DIFFERENCE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WILD TYPE;

ANIMALS; ARSENITES; DRUG RESISTANCE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME INHIBITORS; LEISHMANIA DONOVANI; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; PROTOZOAN PROTEINS; SODIUM COMPOUNDS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

LEISHMANIA DONOVANI;

EID: 70349968083     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2009.08.003     Document Type: Article

References (25)

1. Bente M., Harder S., Wiesgigl M., Heukeshoven J., Gelhaus C., Krause E., Clos J., and Bruchhaus I. Developmentally induced changes of the proteome in the protozoan parasite Leishmania donovani. Proteomics 3 (2003) 1811-1829
2. Biron D.G., Joly C., Galeotti N., Ponton F., and Marche L. The proteomics: a new prospect for studying parasitic manipulation. Behavioural Processes 68 (2005) 249-253
3. Brobey R.K., and Soong L. Establishing a liquid-phase IEF in combination with 2-DE for the analysis of Leishmania proteins. Proteomics 7 (2007) 116-120
4. Chavan H.D., Singh G., and Dey C.S. Confocal microscopic investigation of tubulin distribution and effect of paclitaxel on posttranslationally modified tubulins in sodium arsenite resistant Leishmania donovani. Experimental Parasitology 116 (2007) 320-326
5. Clayton C.E. Life without transcriptional control? From fly to man and back again. EMBO Journal 21 (2002) 1881-1888
6. Cuervo P., de Jesus J.B., Junqueira M., Mendonça-Lima L., González L.J., Betancourt L., Grimaldi Jr. G., Domont G.B., Fernandes O., and Cupolillo E. Proteome analysis of Leishmania (Viannia) braziliensis by two dimensional gel electrophoresis and mass spectrometry. Molecular and Biochemical Parasitology 154 (2007) 6-21
7. Drummelsmith J., Brochu V., Girard I., Meisser N., and Ouellette M. Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms. Molecular and Cellular Proteomics 2 (2003) 146-155
8. Drummelsmith J., Girard I., Trudel N., and Ouellette M. Differential protein expression analysis of Leishmania major reveals novel roles for methionine adenosyl transferase and s-adenosylmethionine in methotrexate resistance. Journal of Biological Chemistry 279 (2004) 33273-33280
9. Foucher A.L., McIntosh A., and Douce G. A proteomic analysis of arsenical drug resistance in Trypanosoma brucei. Proteomics 6 (2006) 2726-2732
10. Góngora R., Acestor N., Quadroni M., Fasel N., Saravia N.G., and Walker J. Mapping the proteome of Leishmania Viannia parasites using two dimensional polyacrylamide gel electrophoresis and associated technologies. Biomedica 23 (2003) 153-160
11. Jalal C., Uhlmann-Schiffler H., and Stahl H. Redundant role of DEAD box proteins p68 (Ddx5) and p72/p82 (Ddx17) in ribosome biogenesis and cell proliferation. Nucleic Acids Research 35 (2007) 3590-3601
12. Kaur J., and Dey C.S. Putative P-Glycoprotein expression in arsenite resistant Leishmania donovani down-regulated by verapamil. Biochemical and Biophysical Research Communications 271 (2000) 615-619
13. Lee S.T., Liu H.Y., Lee S.P., and Tarn C. Selection of arsenite resistance causes reversible changes in maxicircle composition and kinetoplast organizqtion in Leishmania mexicana. Molecular Cell Biology 14 (1994) 587-596
14. Lee-Chen S.F., Gurr J.H., Lin I.B., and Jan K.Y. Arsenite enhances DNA strand breaks and cell killing of methyl methanesulfonate treated cells by inhibiting the excision of alkali-labile site. Mutation Research 294 (1993) 21-28
15. Leifso K., Cohen-Freue G., Dogra N., Murray A., and McMaster W.R. Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: the Leishmania genome is constitutively expressed. Molecular and Biochemical Parasitology 152 (2007) 35-46
16. Li J.H., and Rossman T.G. Inhibition of DNA ligase activity by arsenite: possible mechanism of its comutagenesis. Molecular Toxicology 2 (1989) 1-9
17. McNicoll F., Drummelsmith J., Muller M., Madore E., Boilard N., Ouellette M., and Papadopoulou B. A combined proteomic and transcriptomic approach to the study of stage differentiation in Leishmania infantum. Proteomics 6 (2006) 3567-3581
18. Nugent P.G., Karsani S.A., Wait R., Tempero J., and Smith D.F. Proteomic analysis of Leishmania mexicana differentiation. Molecular and Biochemical Parasitology 136 (2004) 51-62
19. Okui T., and Fugiwara Y. Inhibition of human excision DNA repair by inorganic arsenic and the comutagenic effect in V79 Chinese hamster cells. Mutation Research 172 (1986) 69-76
20. Oullette M., Drummelsmith J., and Papadopoulou B. Leishmaniasis: drugs in clinic, resistance and new developments. Drug Resistance Updates 7 (2004) 257-266
21. Prasad V., Kaur J., and Dey C.S. Arsenite resistant Leishmania donovani promastigotes express an enhanced membrane P-type adenosine triphosphatase activity that is sensitive to verapamil treatment. Parasitology Research 86 (2000) 661-664
22. Singh G., Chavan H.D., and Dey C.S. Proteomic analysis of miltefosine-resistant Leishmania reveals the possible involvement of eukaryotic initiation factor 4A (eIF4A). International Journal of Antimicrobial Agents 31 (2008) 584-586
23. Singh G., Jayanarayan K.G., and Dey C.S. Arsenite-resistance in Leishmania and possible drug targets. Advances in Experimental Medical Biology 625 (2008) 1-8
24. Singh G., Thakur M., Chakraborti P.K., and Dey C.S. Evidence for the presence of R250G mutation at the ATPase domain of topoisomerase II in an arsenite-resistant Leishmania donovani exhibiting a differential drug inhibition profile. International Journal of Antimicrobial Agents 33 (2009) 80-85
25. Walker J., Gomez M.A., Drummelsmith J., Burchmore R., Girard I., and Ouellette M. Identification of developmentally regulated proteins in Leishmania panamensis by proteome profiling of promastigotes and axenic amastigotes. Molecular and Biochemical Parasitology 30 (2006) 1-10